Page last updated: 2024-10-31

mitoxantrone and Epithelial Ovarian Cancer

mitoxantrone has been researched along with Epithelial Ovarian Cancer in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

ExcerptRelevanceReference
"We treated A2780 ovarian cancer cells with NGF, thapsigargin (Tg), an ER stress inducer and mitoxantrone (Mtx), a chemotherapeutic drug; CRT subcellular localization was analyzed by immunofluorescence followed by confocal microscopy."1.46The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells. ( Ferreira, A; Gabler, F; OrĂ³stica, L; Romero, CA; Selman, A; Vega, M; Vera, CA, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vera, CA1
OrĂ³stica, L1
Gabler, F1
Ferreira, A1
Selman, A1
Vega, M1
Romero, CA1

Other Studies

1 other study available for mitoxantrone and Epithelial Ovarian Cancer

ArticleYear
The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells.
    International journal of oncology, 2017, Volume: 50, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Calreticulin; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cel

2017